Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04950426
PHASE2

Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome

Sponsor: Centre Hospitalier Henri Laborit

View on ClinicalTrials.gov

Summary

The aim of the study is to demonstrate a significant improvement in quality of life specific to patients with fibromyalgia syndrome in patients with fibromyalgia syndrome with comorbid posttraumatic stress disorder, treated with reconsolidation blockade. Patients receive a treatment with propranolol associated with reconsolidation blockade of traumatic story once a week during 6 weeks, with evaluation at inclusion and at 3 months.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

17

Start Date

2021-08-13

Completion Date

2025-01-13

Last Updated

2026-09-09

Healthy Volunteers

No

Interventions

DRUG

Propranolol

One administration of propranolol, once a week during six weeks. Reading by the participant of his/her traumatic story, 75 minutes (+/- 15 min) after propranolol intake.

Locations (2)

Centre Hospitalier Henri Laborit

Poitiers, France

Centre Hospitalier Nord-Deux-Sèvres

Thouars, France